Shijiazhuang, China

Yaran Zhang

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.. Active years: 2019-2020.


% Patents Active = 100.0


 

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yaran Zhang: Innovator in Pharmaceutical Chemistry

Introduction

Yaran Zhang is a notable inventor based in Shijiazhuang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of quinazoline derivatives. With a total of 2 patents, his work focuses on innovative solutions for cancer treatment.

Latest Patents

Zhang's latest patents include a quinazoline derivative, which is described as a pharmaceutical composition that contains the same. This invention also outlines a method for the preparation of the derivative and its application as an anti-cancer drug. The potential of this compound in the pharmaceutical industry highlights Zhang's commitment to advancing medical science.

Career Highlights

Throughout his career, Yaran Zhang has worked with prominent companies in the pharmaceutical sector. Notably, he has been associated with Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. and Cspc Zhongqi Pharmaceutical Technology Co., Ltd. His experience in these organizations has allowed him to collaborate on various innovative projects.

Collaborations

Zhang has worked alongside talented individuals such as Ying Shi and Qingzhi Gao. Their collaborative efforts have contributed to the success of his inventions and the advancement of pharmaceutical research.

Conclusion

Yaran Zhang's contributions to the field of pharmaceutical chemistry, particularly through his patents on quinazoline derivatives, demonstrate his innovative spirit and dedication to improving cancer treatment options. His work continues to inspire advancements in medical research and development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…